Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
History of aspirin use against cancer
Prof Peter Elwood - University of Cardiff, UK
History of aspirin use against cancer ( Prof Peter Elwood - University of Cardiff, UK )
27 Nov 2013
Highlights of the 2013 Aspirin Foundation meeting
Nick Henderson - Aspirin Foundation UK
Highlights of the 2013 Aspirin Foundation meeting ( Nick Henderson - Aspirin Foundation UK )
27 Nov 2013
Novel therapies add to oncologists’ treatment arsenal
Prof Noel Clarke, Prof Maria De Santis, Dr Heather Payne, Dr Kurt Miller
Novel therapies add to oncologists’ treatment arsenal ( Prof Noel Clarke, Prof Maria De Santis, Dr Heather Payne, Dr Kurt Miller )
27 Nov 2013
Overview of BIG CAT grants from AORTIC 2013
Dr James Holland – Co-Founder of AORTIC and Mount Sinai Hospital, New York, USA
Overview of BIG CAT grants from AORTIC 2013 ( Dr James Holland – Co-Founder of AORTIC and Mount Sinai Hospital, New York, USA )
27 Nov 2013
Polygenic susceptibility: What might it tell us?
Sir Bruce Ponder - University of Cambridge, UK
Polygenic susceptibility: What might it tell us? ( Sir Bruce Ponder - University of Cambridge, UK )
14 Nov 2013
Engineering of polymeric nanoparticles for medical applications
Dr Omid Farokhzad - Harvard Medical School, Boston, USA
Engineering of polymeric nanoparticles for medical applications ( Dr Omid Farokhzad - Harvard Medical School, Boston, USA )
14 Nov 2013
Biobanks, rare tumours and the importance of collecting primary material
Dr Andy Hall - Newcastle University, UK
Biobanks, rare tumours and the importance of collecting primary material ( Dr Andy Hall - Newcastle University, UK )
12 Nov 2013
The DietCompLyf study: Breast cancer survival and phytoestrogen consumption
Dr Ruth Swann - University of Westminster, UK
The DietCompLyf study: Breast cancer survival and phytoestrogen consumption ( Dr Ruth Swann - University of Westminster, UK )
12 Nov 2013
The aTTom study: randomised comparison of continuing adjuvant in ER positive or...
Dr Daniel Rea - University of Birmingham, UK
The aTTom study: randomised comparison of continuing adjuvant in ER positive or ER untested early breast cancer ( Dr Daniel Rea - University of Birmingham, UK )
12 Nov 2013
The immune microenvironment as an anti-cancer therapeutic strategy
Dr Lisa Coussens - Oregon Science & Health University, USA
The immune microenvironment as an anti-cancer therapeutic strategy ( Dr Lisa Coussens - Oregon Science & Health University, USA )
12 Nov 2013
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer
Dr Chris Gallagher - Barts and the London NHS Trust, UK
PETROC / OV21: Phase II/III trial of peritoneal treatment for ovarian cancer ( Dr Chris Gallagher - Barts and the London NHS Trust, UK )
12 Nov 2013
The molecular basis of cancer
Dr Gerard Evan - University of Cambrige, UK
The molecular basis of cancer ( Dr Gerard Evan - University of Cambrige, UK )
12 Nov 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation